Announcement on Convening Performance Briefing for 2025 and Q1 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening Performance Briefing for 2025 and Q1 2026
Filed with SSE · · 2 pages · Chinese
Release
Ningbo Menovo Pharmaceutical Co., Ltd. on 6ix
Earlier from Ningbo Menovo Pharmaceutical
- Announcement on Completing Industrial and Commercial Change Registration and Obtaining New Business License
- Announcement on the Lifting and Listing of the 1st Trade Restriction Period for Restricted Shares Granted under the Reserved Granting of the 2024 Restricted Stock Incentive Plan
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Resolutions of the 27th Meeting of the 5th Board of Directors
- Announcement on Progress in Using Idle Raised Funds for Cash Management
Later from Ningbo Menovo Pharmaceutical
- Announcement on No Provision of Financial Aid or Compensation for Investors Participating in Subscription Directly or through Stakeholders in This Issuance of A Shares to Specific Objects
- Announcement on the Lifting and Listing of the 2nd Trade Restriction Period for Restricted Shares Granted under the Initial Granting of the 2024 Restricted Stock Incentive Plan
- Announcement on External Investment
- Announcement on Progress in Outward Investment
- Announcement on Change to "Drug Manufacturing License" of Controlled Subsidiary
Follow Ningbo Menovo Pharmaceutical into a list and get an email when it puts out news.
Follow Ningbo Menovo Pharmaceutical